NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

TherapeuticsMD Inc (NASDAQ: TXMD)

 
TXMD Technical Analysis
2
As on 9th Jun 2023 TXMD STOCK Price closed @ 4.03 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.44 & Strong Buy for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TXMDSTOCK Price

Open 4.04 Change Price %
High 4.13 1 Day 0.01 0.25
Low 3.98 1 Week -0.12 -2.89
Close 4.03 1 Month 0.40 11.02
Volume 31478 1 Year 3.61 859.52
52 Week High 10.40 | 52 Week Low 0.17
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
TXMD
Daily Charts
TXMD
Intraday Charts
Whats New @
Bazaartrend
TXMD
Free Analysis
 
TXMD Important Levels Intraday
RESISTANCE4.32
RESISTANCE4.23
RESISTANCE4.17
RESISTANCE4.11
SUPPORT3.95
SUPPORT3.89
SUPPORT3.83
SUPPORT3.74
 
TXMD Forecast May 2024
4th UP Forecast4.34
3rd UP Forecast4.24
2nd UP Forecast4.18
1st UP Forecast4.12
1st DOWN Forecast3.94
2nd DOWN Forecast3.88
3rd DOWN Forecast3.82
4th DOWN Forecast3.72
 
TXMD Weekly Forecast
4th UP Forecast4.53
3rd UP Forecast4.37
2nd UP Forecast4.27
1st UP Forecast4.17
1st DOWN Forecast3.89
2nd DOWN Forecast3.79
3rd DOWN Forecast3.69
4th DOWN Forecast3.53
 
TXMD Forecast2024
4th UP Forecast26.23
3rd UP Forecast19.11
2nd UP Forecast14.71
1st UP Forecast10.31
1st DOWN Forecast-2.25
2nd DOWN Forecast-6.65
3rd DOWN Forecast-11.05
4th DOWN Forecast-18.17
 
 
TXMD Other Details
Segment EQ
Market Capital 323245216.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
TXMD Address
TXMD
 
TXMD Latest News
 
Your Comments and Response on TherapeuticsMD Inc
 
TXMD Business Profile
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Address: 951 Yamato Road, Boca Raton, FL, United States, 33431
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service